- Home
- / Ci Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ci Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥1.2 K
2024-10-29
Market Capitalization
¥59.2 B
2024-10-29
Revenue
¥67.5 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 25.8B | 28.8B | 37.4B | 41.2B | 42.9B | 45.6B | 67.5B |
| Cost of goods sold | 18.7B | 20.7B | 25.8B | 29.3B | 30.8B | 32.6B | 46.0B |
| Gross profit | 7.1B | 8.0B | 11.6B | 12.0B | 12.1B | 13.0B | 21.5B |
| Gross profit margin, % | 28.0% | 30.9% | 29.0% | 28.1% | 28.5% | 31.9% | |
| Operating expense total | 4.9B | 5.7B | 6.6B | 7.1B | 7.7B | 9.0B | 16.7B |
| Depreciation and amortization | 232.4M | 288.4M | 271.8M | 345.0M | 396.0M | 1.0B | 2.4B |
| EBITDA | 2.1B | 2.4B | 5.0B | 4.9B | 4.4B | 4.1B | 4.8B |
| EBITDA margin, % | 8.3% | 13.3% | 11.8% | 10.2% | 8.9% | 7.2% | |
| EBIT | 1.9B | 2.1B | 4.7B | 4.3B | 4.0B | 3.1B | 7.2B |
| EBIT margin, % | 7.3% | 12.6% | 10.5% | 9.3% | 6.7% | 10.6% | |
| Interest income | 34.3M | 30.4M | 25.8M | 21.0M | 31.0M | 37.0M | 47.0M |
| Interest expense | 17.0M | 61.0M | |||||
| Pre tax profit | 1.9B | 2.1B | 4.5B | 4.3B | 3.9B | 3.2B | 7.1B |
| Income tax expense | 535.6M | 643.5M | 1.5B | 1.5B | 1.3B | 1.1B | 777.0M |
| Net Income | 1.3B | 1.5B | 2.9B | 2.8B | 2.5B | 2.1B | 6.3B |